Breaking news FDA approves remdesivir for some non-hospitalized patients Gennaio 22, 2022 The United States Food and Drug Administration (FDA) expanded its approval of Gilead Sciences antiviral drug Veklury (remdesivir) to treat some non-hospitalized COVID-19 patients. The agency said the…